Insiders · Profile

Milligan Michael Lee

See Remarks at Neumora Therapeutics. Filing since 18 Feb 2025. CIK 0001993953

Company
Date
Role
Action
Shares
Amount
Of holding
17 Feb 2026
See Remarks
Sold on a plan
1,436
$5.12K
6.4%
18 Feb 2025
See Remarks
Sold on a plan
1,978
$3.35K
8.1%
2 decisions on file.